Reuters -- Spanish biotechnology company Zeltia (ZEL.MC) said on Wednesday that its PharmaMar unit has reached a deal with the U.S. company Medimetriks to develop its Kahalalide F drug in the treatment of psoriasis.
Reuters -- Spanish biotechnology company Zeltia (ZEL.MC) said on Wednesday that its PharmaMar unit has reached a deal with the U.S. company Medimetriks to develop its Kahalalide F drug in the treatment of psoriasis.
